Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001216077 | SCV001387852 | pathogenic | not provided | 2021-11-06 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 945435). This premature translational stop signal has been observed in individual(s) with Gitelman syndrome (PMID: 12008755, 30596175). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe846*) in the SLC12A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC12A3 are known to be pathogenic (PMID: 20848653, 22009145, 25841442). For these reasons, this variant has been classified as Pathogenic. |
Natera, |
RCV001833882 | SCV002089373 | pathogenic | Familial hypokalemia-hypomagnesemia | 2020-01-26 | no assertion criteria provided | clinical testing |